Colon & Colorectal Cancer · Article 62

How Should Suspected Small-Bowel Bleeding Be Investigated?

Small-bowel bleeding evaluation requires a structured, evidence-based clinical approach. This review summarizes the key diagnostic, management, monitoring and decision points for gastroenterology and hepatology practice.

Small-bowel bleeding evaluation clinical reference — Related free clinical resource: First Principles of Gastroenterology and Hepatology.

Small-bowel bleeding evaluation: practical clinical approach

This page focuses on Small-bowel bleeding evaluation with emphasis on decisions that change patient care, common pitfalls, and the current evidence base.

External guidance for Small-bowel bleeding evaluation

Clinical takeaway: For Small-bowel bleeding evaluation, decisions should integrate current guidelines, patient-specific risk, and the evidence summarized below.

Answer in brief: After adequate upper endoscopy and colonoscopy fail to identify a source, stable suspected small-bowel bleeding is usually evaluated with video capsule endoscopy, often followed by device-assisted enteroscopy when a treatable lesion is found. CT or MR enterography is useful when a mass, Crohn’s disease or stenosis is suspected. Hemodynamically significant active bleeding may require CT angiography, angiography or urgent intervention instead.

Confirm that the first examinations were adequate

Before moving downstream, review the quality and completeness of EGD and colonoscopy and whether the bleeding pattern suggests a missed upper or colonic lesion. Repeat conventional endoscopy selectively when the initial examination was limited or clinical suspicion remains high.

Capsule endoscopy is often the next test

Capsule endoscopy provides broad mucosal visualization and is particularly useful for angioectasia, ulcers and subtle inflammatory lesions. Diagnostic yield is highest when performed relatively close to an overt bleeding episode.

Use enterography for mural disease and obstruction risk

Cross-sectional enterography complements capsule imaging. It is particularly valuable for suspected tumors, Crohn’s disease, mural thickening or a possible stricture. When capsule retention is a concern, imaging or a patency strategy may precede capsule ingestion.

Deep enteroscopy is usually therapeutic or targeted

Device-assisted enteroscopy is invasive and resource-intensive, so it is commonly directed by capsule or imaging findings. It permits biopsy, hemostasis, dilation and other intervention.

Active severe bleeding follows a different pathway

Unstable patients require resuscitation first. CTA can localize active bleeding quickly; catheter angiography allows embolization. Test choice depends on bleeding rate, hemodynamics and local expertise.

What trainees should remember

Small-bowel bleeding work-up is sequential: verify prior endoscopy, use capsule for mucosal discovery, enterography for mural/structural disease, and deep enteroscopy to biopsy or treat targeted lesions.

Frequently asked questions

Is “obscure GI bleeding” still the preferred term?

Current practice increasingly uses “suspected small-bowel bleeding” once adequate upper and lower endoscopy are negative.

Should capsule endoscopy be used during brisk unstable bleeding?

Not as the first priority. Stabilization and rapid localization with acute-bleeding imaging/intervention may be more appropriate.

References and further reading

1. Thomson ABR. Endoscopy and Diagnostic Imaging, Parts I-II. CAPstone Academic Publishers; 2012.

2. Thomson ABR. Practice Review in Gastroenterology. CAPstone Academic Publishers; 2014.